Breast Cancer Update Home - Oncology Leader Commentary

Home: Oncology Leader Commentary: John F. Robertson, MD, FRCS

Click on the topic below for comments by Dr John F Robertson to comment on. You will also find links to related articles and clinical trials.

Faslodex: Mechanism of action: Tissue effects
Side effects of Faslodex
Faslodex injection
Faslodex: Downregulation of estrogen receptor
Arimidex in premenopausal patients progressing on Zoladex
Zoladex plus Arimidex as adjuvant therapy
Arimidex versus tamoxifen as first-line therapy

Home

Patrick I Borgen, MD

Aman Buzdar, MD

Nancy E Davidson, MD

J. Michael Dixon, MD

Armando Giuliano, MD

I Craig Henderson, MD

David Krag, MD

Gershon Locker, MD

Charles Loprinzi, MD

Richard Margolese, MD

Monica Morrow, MD

C Kent Osborne, MD

Sir Richard Peto, FRS

Kathy I Pritchard, MD

John F Robertson, MD,FRCS

Andrew D Seidman, MD

George W Sledge, MD

Home · Contact us

Terms of use and general disclaimer